US Stock MarketDetailed Quotes

ALT Altimmune

Watchlist
  • 7.680
  • +0.220+2.95%
Close Nov 8 16:00 ET
  • 7.689
  • +0.009+0.12%
Post 20:01 ET
545.82MMarket Cap-4711P/E (TTM)

Altimmune Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Altimmune Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
620.00
-99.83%
EPS
-0.36
+7.69%
Analyst Rating
Strong Buy

Oct 31, 2024

Altimmune Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 31.251M --
Nov 12, 2024 2024/Q3 -- / 620.000 --
Aug 8, 2024 2024/Q2 5.000K / 620.000 --
May 9, 2024 2024/Q1 5.000K / 0.000 --
Mar 27, 2024 2023/Q4 37.000K / 2.140K --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 31.251M--
Nov 12, 20242024/Q3-- / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Mar 27, 20242023/Q437.000K / 2.140K--

Unlock Free Earnings Estimates

Altimmune Earnings Reports

  • Altimmune | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:10

  • Altimmune | 10-Q: Q1 2024 Earnings Report

    May 10 05:13

  • Altimmune | 10-K: FY2023 Annual Report

    Mar 28 04:05

  • Altimmune | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 05:08

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Weight Loss Drugs
    Weight Loss Drugs
    Intraday+1.93%